NAFLD Pediatric Database 2
NCT01061684 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 969
Last updated 2022-02-23
Summary
The NAFLD Database 2 will recruit at least 650 new pediatric participants with liver biopsies and contemporaneous biosamples, and will also invite pediatric participants from the prior NAFLD Database and TONIC trial (50 with a recent biopsy and 150 without a contemporaneous biopsy) to enroll in the NAFLD Pediatric Database 2 study. Combining the new and continuing participants leads to a recruitment goal for the pediatric Database 2 of 850 pediatric participants during the enrollment period.
Conditions
Sponsors & Collaborators
-
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
collaborator NIH -
Johns Hopkins Bloomberg School of Public Health
lead OTHER
Principal Investigators
-
Ed Doo, MD · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Eligibility
- Min Age
- 2 Years
- Max Age
- 17 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2010-01-20
- Primary Completion
- 2020-05-31
- Completion
- 2020-05-31
Countries
- United States
Study Locations
More Related Trials
-
Hepatoprotective Measures for Children at High Risk of NAFLD
NCT06918080 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4
-
The Very Large Database of Lipids
NCT01698489 ·Status: ACTIVE_NOT_RECRUITING
-
Gemcabene for the Treatment of Pediatric NAFLD
NCT03436420 ·Status: TERMINATED ·Phase: PHASE2
-
Fatty Liver Disease in Obese Children
NCT02117700 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Pediatric Longitudinal Cohort Study of Chronic Pancreatitis
NCT03672422 ·Status: COMPLETED
-
A Carbohydrate-restricted Diet to Reverse Fatty Liver in Adolescents With Obesity
NCT02787668 ·Status: COMPLETED ·Phase: NA
-
Treating Pediatric NAFLD with Nutrition
NCT05499585 ·Status: COMPLETED ·Phase: NA
-
Healthy Eating Through Reduction Of Excess Sugar
NCT02948647 ·Status: COMPLETED ·Phase: NA
-
Cysteamine Bitartrate Delayed-Release for the Treatment of NAFLD in Children
NCT01529268 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Low Dose Fat for the Prevention of Liver Disease in Babies With Gastrointestinal Disorders
NCT01373918 ·Status: TERMINATED ·Phase: PHASE4
-
SGLT2 Inhibitors as a Novel Treatment for Pediatric Non-Alcoholic Fatty Liver Disease
NCT03867487 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Evaluation of Intestinal Microbiome in Obese Kids
NCT00816296 ·Status: WITHDRAWN
-
Expanded Access of Omegaven IV Fat Emulsion to Infants and Children With PNALD
NCT02929303 ·Status: APPROVED_FOR_MARKETING
-
Effects of Docosahexaenoic Acid (DHA) on Children With Nonalcoholic Fatty Liver Disease (NAFLD)
NCT00885313 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Nutritional Assessment Tool in Childhood Chronic Liver Disease
NCT02802761 ·Status: COMPLETED
-
A Clinical Study of Enlicitide Decanoate in People With Liver Function Problems (MK-0616-030)
NCT06575959 ·Status: COMPLETED ·Phase: PHASE1
-
Pentoxifylline Therapy in Biliary Atresia
NCT01774487 ·Status: TERMINATED ·Phase: PHASE2
-
Phase II Pilot Study to Compare the Bioavailability of Buffered, Enteric-Coated Ursodiol With Unmodified Ursodiol for Chronic Cholestatic Liver Disease and Cystic Fibrosis-Associated Liver Disease
NCT00004315 ·Status: UNKNOWN ·Phase: PHASE2
-
Treatment of Nonalcoholic Fatty Liver Disease in Children (TONIC)
NCT00063635 ·Status: COMPLETED ·Phase: PHASE3
-
Osmotic Fragility in Red Blood Cells of Pediatric Patients With Cholestatic Liver Disease
NCT05582447 ·Status: ACTIVE_NOT_RECRUITING
-
Study of Tauroursodeoxycholic Acid for Hepatobiliary Disease in Cystic Fibrosis
NCT00004441 ·Status: COMPLETED ·Phase: NA
-
Standard Lipid Therapy vs IVFE Minimization for Prevention of PNALD
NCT02357576 ·Status: COMPLETED ·Phase: PHASE3
-
SMOFLipid in Patients Who Are Intralipid Intolerant
NCT03054948 ·Status: WITHDRAWN ·Phase: PHASE4
-
Ivacaftor Impact in an Adolescent Without a Cystic Fibrosis-Associated CFTR (Cystic Fibrosis Transmembrane Conductance Regulator) Mutation for Chronic Pancreatitis: Single-Patient Study Tracking Flare Frequency and Health Data Compared to Historical Records.
NCT07022327 ·Status: ACTIVE_NOT_RECRUITING
-
Safety and Efficacy Study of Ursodeoxycholic Acid Therapy in Pediatric Primary Sclerosing Cholangitis
NCT01088607 ·Status: COMPLETED ·Phase: PHASE1